Lighthouse Lab Services, a portfolio company of NaviMed Capital, has received a majority growth investment from Martis Capital
Martis has made a majority investment in Lighthouse, alongside current investors NaviMed and the company’s management team. Lighthouse is an end-to-end provider of turnkey, build-out and management services for clinical labs across the United States. The company provides a comprehensive suite of solutions across outsourced lab management, consulting, recruiting, supply chain management, compliance, equipment sales and more. Lighthouse serves over 1,000 laboratory clients, including physician office, reference and hospital labs.
Mark Roth, Chief Executive Officer of Lighthouse, commented, “This is a tremendous milestone for the entire Lighthouse team. We are thrilled to have the opportunity to work with Martis to advance our mission and help laboratories across the country start, run and grow quality testing operations. We have had two great years working with NaviMed and are delighted that they will remain involved in this next chapter as well. With this amazing support, I couldn’t be more excited for the bright future of Lighthouse.”
Mario Moreno, a Partner at Martis, commented, “We are thrilled to partner with such a strong team and support Lighthouse’s service quality and innovation in the diagnostic laboratory end market by providing high value to patients, providers and payors alike.”
“NaviMed was fortunate to support Lighthouse and its world-class management team in the early stages of executing its vision to service providers, employers and labs with a new lab operating model. We are excited to continue to work with this exceptional company through its next phase of growth,” said, NaviMed’s Co-founder and Managing Director, Dr. Bijan Salehizadeh.
Tony Crisman, Managing Director in Lincoln’s Healthcare Group, commented, “Mark Roth and his leadership team have built Lighthouse into a high growth platform since partnering with NaviMed. I am excited for the accelerated execution of the company’s vision, with the support of Martis.”
Lincoln served as the exclusive financial advisor to Lighthouse.
About Lighthouse Lab Services
Lighthouse provides an end-to-end suite of services enabling customers to start, run and grow their clinical labs. Service offerings include assistance with licensure and compliance with accreditation requirements, scientific method development and validation for a variety of applications ranging from toxicology to infectious disease, recruitment of Lab Directors and other lab staff as well as ongoing operational support. The company boasts a deep bench of doctorate and masters-level, analytical chemists, pharmacologists, toxicologists and laboratory scientists as well as experienced teams specializing in recruiting and staffing for labs. Lighthouse is headquartered in Charlotte, North Carolina. Learn more at www.lighthouselabservices.com.
About Martis Capital
Martis is a private equity firm focused exclusively on the healthcare industry. The Martis team manages more than $1.3 billion of equity capital and is currently investing out of its third fund. With offices in San Francisco, California, and Washington, D.C., Martis seeks to invest in middle market, growth oriented companies that provide innovative and cost-effective products and services, within targeted segments of the North American healthcare industry. Learn more at www.martiscapital.com.
About NaviMed Capital
NaviMed is a Washington, D.C.-based, private equity firm with over $400 million of assets under management that focuses exclusively on the healthcare industry. NaviMed invests in fast-growing, lower-middle market, healthcare businesses that it believes are poised to benefit from the reform and technology innovation forces that are reshaping the healthcare industry. The firm focuses on healthcare services, healthcare information technology, hospital products and pharmaceutical services businesses. NaviMed targets profitable private companies with up to $10 million of EBITDA and double-digit revenue growth. NaviMed’s senior investment team has a track record of value creation, spanning, in the aggregate, dozens of investments and more than $11 billion of enterprise value created over the course of their combined careers. Learn more at www.navimed.com
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.